Skip to main content
SNPSSynopsys, Inc.Sell5.4·$373.36-0.09%
SellModerate Confidence
Investment thesis

Synopsys delivers 42% revenue growth and an elite Rule-of-40 score of 83, but the stock is in deep technical distress with RSI at 26 near capitulation levels, consecutive earnings misses, and a forward P/E of 26.3x that prices in a recovery the fundamentals have yet to validate.

Thesis pillars

  • 42pct Revenue Growth Elite Rule Of 40Stable
  • Consecutive Earnings Misses SignalStable
  • Capitulation Risk At Rsi 26Stable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Synopsys, Inc. (SNPS) Stock Analysis

Falling Knife setup · Catalyst-Driven edge

SellGrowthShortModerate Confidence

Technology · Software - Infrastructure

Sell if holding. Momentum 1.9/10 is below the 5.0 floor at $373.36 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-MA, MA slope -2.4%/30d (confirmed downtrend).

Synopsys sells EDA tools, simulation and analysis software (via the Ansys portfolio), and semiconductor IP across Design Automation and Design IP segments to chip designers and engineering companies globally. Time-based licenses and upfront hardware/IP sales drive revenue; the... Read more

$373.36+36.4% A.UpsideScore 5.4/10#84 of 109 Software - Infrastructure
QualityF-score7 / 9FCF yield4.95%
Stop $355.02Target $507.99(analyst − 10%)A.R:R 4.1:1
Analyst target$564.43+51.2%25 analysts
$507.99our TP
$373.36price
$564.43mean
$650

Sell if holding. Momentum 1.9/10 is below the 5.0 floor at $373.36 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-MA, MA slope -2.4%/30d (confirmed downtrend). Chart setup: Death cross, below all MAs, RSI 21, MACD bearish. Score 5.4/10, moderate confidence.

Passes 6/9 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 27d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-31
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Aug 26, 202627d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Positive insider activity
Analyst upside: 36%
Risks
Negative momentum
Below 200-MA, MA slope -2.4%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)87.7
P/E (Fwd)21.6
Mkt Cap$71.6B
EV/EBITDA47.1
Profit Mgn8.9%
ROE3.8%
Rev Growth41.9%
Beta1.22
DividendNone
Rating analysts31

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C1.44bearish
IV60%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographicsales outside the United States
    10-K Item 1A: 'We derive roughly half of our revenue from sales outside the United States'
  • MEDIUMCustomersmall number of large customers
    10-K Item 1A: 'we depend on a relatively small number of large customers for a large portion of our revenues'

Material Events(8-K, last 90d)

  • 2026-05-27Item 1.01MEDIUM
    Synopsys entered Cooperation Agreement with Elliott Investment Management L.P. on May 26, 2026. Board agreed to appoint Jesse Cohn (Elliott representative) as independent director effective June 1, 2026, with initial term through 2027 Annual Meeting.
    SEC filing →
  • 2026-05-27Item 5.02LOW
    Jesse Cohn appointed to Synopsys Board as independent director effective June 1, 2026, also joining Corporate Governance and Nominating Committee. Appointment made pursuant to Cooperation Agreement with Elliott. No departure.
    SEC filing →
  • 2026-04-20Item 5.02LOW
    Synopsys stockholders approved Amended and Restated Equity Incentive Plan at April 16, 2026 Annual Meeting, adding non-employee directors as eligible recipients. Board and Compensation Committee had previously approved subject to stockholder vote.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Obv
1.0
Ma Position
1.0
Rsi
3.0
Volume
4.7
Capitulation risk (RSI 21, below 200MA)Volume distribution (falling OBV)Below 200-MA, MA slope -2.4%/30d — confirmed downtrend
GatesMomentum 1.9<4.5Death cross (50MA < 200MA)Executive change: officer departure/appointmentA.R:R 4.1 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 27d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Speculative
RSI
21 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $366.00Resistance $453.91

Price Targets

$355
$508
A.Upside+36.4%
A.R:R4.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 1.9 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-26 (27d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is SNPS stock a buy right now?

Sell if holding. Momentum 1.9/10 is below the 5.0 floor at $373.36 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Below 200-MA, MA slope -2.4%/30d (confirmed downtrend). Chart setup: Death cross, below all MAs, RSI 21, MACD bearish. Prior stop was $355.02. Score 5.4/10, moderate confidence.

What is the SNPS stock price target?

Take-profit target: $507.99 (+36.4% upside). Prior stop was $355.02. Stop-loss: $355.02.

What are the risks of investing in SNPS?

Negative momentum; Below 200-MA, MA slope -2.4%/30d (confirmed downtrend).

Is SNPS overvalued or undervalued?

Synopsys, Inc. trades at a P/E of 87.7 (forward 21.6). TrendMatrix value score: 4.6/10. Verdict: Sell.

What do analysts say about SNPS?

31 analysts cover SNPS with a consensus score of 4.0/5. Average price target: $564.

What does Synopsys, Inc. do?Synopsys sells EDA tools, simulation and analysis software (via the Ansys portfolio), and semiconductor IP across...

Synopsys sells EDA tools, simulation and analysis software (via the Ansys portfolio), and semiconductor IP across Design Automation and Design IP segments to chip designers and engineering companies globally. Time-based licenses and upfront hardware/IP sales drive revenue; the July 2025 Ansys merger expanded capabilities into multiphysics simulation for aerospace, automotive, and healthcare. Roughly half of revenue is from outside the United States.

Related stocks: GEN (Gen Digital Inc.) · KSPI (Joint Stock Company Kaspi.kz - ) · CPAY (Corpay, Inc.) · PAYP (PayPay Corporation - American D) · ORCL (Oracle Corporation)
Home Stocks SNPS

Latest news

Latest News

Benzinga4d agoProduct
Benzinga4d agoProduct
Benzinga10d ago
Benzinga11d ago
Benzinga11d ago
Benzinga12d ago
Benzinga12d ago
Benzinga14d ago
Benzinga14d ago
Benzinga16d ago
Benzinga25d agoProduct
Benzinga28d ago
Benzinga38d agoAnalyst
Benzinga38d agoAnalyst
Benzinga39d agoAnalyst
Benzinga40d ago
Benzinga42d ago
Benzinga53d ago
Benzinga61d agoProduct
Benzinga61d ago
Loading more...